
BHC Valuation
Bausch Health Companies Inc
- Overview
- Forecast
- Valuation
- Earnings
BHC Relative Valuation
BHC's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average, adjusted by weights. If the market price exceeds this fair value range, BHC is overvalued; if below, it's undervalued.
Historical Valuation
Bausch Health Companies Inc (BHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 1.64 is considered Undervalued compared with the five-year average of 3.49. The fair price of Bausch Health Companies Inc (BHC) is between 35.70 to 50.31 according to relative valuation methord. Compared to the current price of 6.77 USD , Bausch Health Companies Inc is Undervalued By 81.04%.
Relative Value
Fair Zone
35.70-50.31
Current Price:6.77
81.04%
Undervalued
Trailing
Forward
P/E
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
-2.12
P/B
Median3y
-3.03
Median5y
-11.13
49.04
FCF Yield
Median3y
13.51
Median5y
13.02
Competitors Valuation Multiple
The average P/S ratio for BHC's competitors is 123.82, providing a benchmark for relative valuation. Bausch Health Companies Inc Corp (BHC) exhibits a P/S ratio of 0.25, which is -99.80% above the industry average. Given its robust revenue growth of 4.92%, this premium appears unsustainable.
P/S
P/E
EV/EBITDA
EV/EBIT
P/S
People Also Watch

TBBK
Bancorp Inc
63.665
USD
-8.55%

MCY
Mercury General Corp
69.650
USD
+0.48%

HUT
Hut 8 Corp
20.380
USD
-3.60%

YELP
Yelp Inc
34.700
USD
-1.06%

PSMT
PriceSmart Inc
107.190
USD
+2.45%

STNG
Scorpio Tankers Inc
44.090
USD
-1.23%

FFBC
First Financial Bancorp
24.860
USD
+4.28%

GT
Goodyear Tire & Rubber Co
10.910
USD
-3.28%

PRVA
Privia Health Group Inc
19.705
USD
+0.03%

GRBK
Green Brick Partners Inc
66.150
USD
+1.04%
FAQ

Is Bausch Health Companies Inc (BHC) currently overvalued or undervalued?
Bausch Health Companies Inc (BHC) is now in the Undervalued zone, suggesting that its current forward PE ratio of 1.64 is considered Undervalued compared with the five-year average of 3.49. The fair price of Bausch Health Companies Inc (BHC) is between 35.70 to 50.31 according to relative valuation methord. Compared to the current price of 6.77 USD , Bausch Health Companies Inc is Undervalued By 81.04% .

What is Bausch Health Companies Inc (BHC) fair value?

How does BHC's valuation metrics compare to the industry average?

What is the current P/B ratio for Bausch Health Companies Inc (BHC) as of Jul 27 2025?

What is the current FCF Yield for Bausch Health Companies Inc (BHC) as of Jul 27 2025?

What is the current Forward P/E ratio for Bausch Health Companies Inc (BHC) as of Jul 27 2025?
